Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2003Vol. 11pp. -
479
m2003supportivepiperacillin-tazobactam
Abstract
Piperacillin-tazobactam monotherapy is significantly more effective and cost-efficient than ceftriaxone plus gentamicin as first-line therapy in febrile neutropenic patients with hematological malignancies.